Agilent Technologies (NYSE:A – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Monday, November 25th. Analysts expect the company to announce earnings of $1.41 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the firm posted $1.43 EPS. The company’s quarterly revenue was down 5.6% on a year-over-year basis. On average, analysts expect Agilent Technologies to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.
Agilent Technologies Trading Down 2.4 %
A opened at $127.07 on Monday. Agilent Technologies has a 1-year low of $112.06 and a 1-year high of $155.35. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The company has a market cap of $36.51 billion, a P/E ratio of 26.36, a PEG ratio of 5.59 and a beta of 1.07. The company’s 50 day moving average is $138.73 and its 200-day moving average is $138.00.
Agilent Technologies Dividend Announcement
Insider Buying and Selling
In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 7.51 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 11,995 shares of company stock worth $1,739,510.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the stock. Wells Fargo & Company assumed coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price on the stock. TD Cowen boosted their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Bank of America boosted their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Citigroup increased their target price on Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Stifel Nicolaus restated a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a research report on Monday, August 26th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $144.36.
Read Our Latest Stock Report on A
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
- Five stocks we like better than Agilent Technologies
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to Invest in Biotech Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.